XIST and breast cancer: The levels of XIST in 16 breast cancer cell lines, led to their grouping into two major classes, one is a low dose sensitive group, in which the cancer stem cells were differentiated by abexinostat and a high dose sensitive group whose cancer stem cell populations were stable [245].